Recall archive / FDA drug enforcement
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by... — FDA record D-0654-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Mar 2, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
- Reason
- CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
- Classification
- Class II
- Recalling firm
- Golden State Medical Supply Inc.
- Quantity
- 401 bottles
- Agency-reported status
- Terminated
- Source record identifier
- D-0654-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: GS027852, Expiry: 06/2022. |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Distributed to 1 wholesaler/distributor
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Mar 23, 2022
- Recall initiation date
- Mar 2, 2022
- Center classification date
- Mar 15, 2022
- Termination date
- Sep 13, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.